Global Cephalosporin Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 14.4% - ResearchAndMarkets.com
Jun. 13, 2018
DUBLIN--(BUSINESS WIRE)--Jun 13, 2018--The "Cephalosporin Market by Generation, Type, Route of Drug Administration, and Application - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.
The global cephalosporin market is estimated to reach $1,99,754 million by 2023 from $77,764 million in 2016, growing at a CAGR of 14.4% from 2017 to 2023.
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep throat, staph infections, tonsillitis, bronchitis, otitis media, and gonorrhea.
The major factors that contribute to the growth of the cephalosporin market include increase in R&D activities to develop highly efficient & safe drugs; upsurge in use of combination therapies; and rise in incidence of pneumonia, tonsillitis, bronchitis, and gonorrhea. Moreover, increased approvals of drugs and growth in awareness about various infections & antibiotic resistance propel the market growth.
The global cephalosporin market is segmented on the basis of generation, type, route of drug administration, application, and region. Based on generation, the market is divided into first-generation cephalosporin, second-generation cephalosporin, third-generation cephalosporin, fourth-generation cephalosporin, and fifth-generation cephalosporin. By type, it is bifurcated into branded and generics.
Depending on route of drug administration, it is classified into injection and oral. The applications covered in the study include respiratory tract infection, skin infection, ear infection, urinary tract infection, sexually transmitted infection, and others.
Companies Mentioned:Allergan Plc Bristol-Myers Squibb Company Lupin Limited Sanofi Eli Lilly and Company F. Hoffmann-La Roche Ltd. GlaxoSmithKline Plc Merck & Co., Inc. Pfizer Inc. Teva Pharmaceutical Industries Ltd.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Cephalosporin Market, by Generation
5 Cephalosporin Market, by Type
6 Cephalosporin Market, by Route of Drug Administration
7 Cephalosporin Market, by Application
8 Cephalosporin Market, by Region
9 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/nh3csm/global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180613005443/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 06/13/2018 04:47 AM/DISC: 06/13/2018 04:47 AM